RecruitingNCT05257551

TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)

Tempus Small Cell Lung Cancer Observational Study (Sculptor): A Tissue and Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients With Small Cell Lung Cancer (SCLC) Using Comprehensive Next-Generation Sequencing (NGS) Assays


Sponsor

Tempus AI

Enrollment

200 participants

Start Date

Jul 13, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The study is a non-interventional evaluation of participants with extensive stage (ES) SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA and CTC biomarker profiling during standard of care therapy in both first and second line treatment.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study is collecting information and tumor samples from people with small cell lung cancer (SCLC) to better understand why some patients respond well to treatment and others do not. Researchers will look at tumor genetics and other biological markers to guide future treatment decisions. **You may be eligible if...** - You have been diagnosed with small cell lung cancer (confirmed by tissue biopsy) - Your cancer is at an extensive stage (has spread beyond one lung area) - You are about to start first-line treatment with etoposide plus carboplatin plus an immunotherapy drug (atezolizumab or durvalumab) - You are in generally good physical condition (ECOG 0–2) - You are able to provide a tumor tissue sample **You may NOT be eligible if...** - Your diagnosis was confirmed only by a fine needle aspirate (unless approved by the study doctor) - You are unable or unwilling to provide tumor tissue - You are not able to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservation

No intervention


Locations(11)

Cancer and Blood Specialty Clinic

Los Alamitos, California, United States

University of Colorado

Aurora, Colorado, United States

Illinois Cancer Care

Peoria, Illinois, United States

Johns Hopkins University

Baltimore, Maryland, United States

Englewood Health Medical Center

Englewood, New Jersey, United States

University of North Carolina

Chapel Hill, North Carolina, United States

TriHealth Cancer Institute

Cincinnati, Ohio, United States

Ohio State University

Columbus, Ohio, United States

OhioHealth Research Institute

Columbus, Ohio, United States

Oklahoma Cancer Specialists and Research Institutes

Tulsa, Oklahoma, United States

Cancer Care Association of York

York, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05257551


Related Trials